Search
Patexia Research
Case number 2017-1538

Bayer Pharma AG v. Watson Laboratories Inc. > Documents

Date Field Doc. No.Description (Pages)
Jul 5, 2017 19 MOTION of Appellant Watson Laboratories Inc. and Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GmbH and Bayer Pharma AG to terminate appeal through Dismissal. [Consent: unopposed]. Service: 07/05/2017 by email. [444099] [Michael Nutter] [Entered: 07/05/2017 10:49 AM] (7)
Jul 5, 2017 20 ORDER granting motion to terminate appeal [19] filed by Appellees Bayer Pharma AG, Bayer Intellectual Property GmbH, Bayer HealthCare Pharmaceuticals Inc. and Appellant Watson Laboratories Inc.; issuing mandate. Service as of this date by Clerk of Court. [444126] [MJL] [Entered: 07/05/2017 11:40 AM] (2)
Jun 13, 2017 18 **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [17] filed by Appellant Watson Laboratories Inc. The brief is due 07/05/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [438627] [MJL] [Entered: 06/13/2017 09:23 AM] (0)
Jun 12, 2017 17 MOTION of Appellant Watson Laboratories Inc. to extend the time to 07/05/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/12/2017 by email. [438468] [Michael Nutter] [Entered: 06/12/2017 03:22 PM] (7)
May 26, 2017 14 MOTION of Appellant Watson Laboratories Inc. to extend time until 06/13/2017 to file (Opening Brief). [Consent: unopposed]. Service: 05/26/2017 by email. [434527] [Michael Nutter] [Entered: 05/26/2017 01:58 PM] (7)
May 26, 2017 15 **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [14] filed by Appellant Watson Laboratories Inc. The brief is due 06/13/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [434570] [MJL] [Entered: 05/26/2017 02:58 PM] (0)
May 26, 2017 16 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The motion filed by Appellant [14] selected an incorrect relief ("extend time to file (other)"). CORRECTION: When requesting an extension for an appellant's opening brief, the appropriate relief is "extend time to file appellant/petitioner principal brief." For future motions, please ensure the correct relief is selected. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [434574] [MJL] [Entered: 05/26/2017 03:02 PM] (0)
Mar 15, 2017 12 MOTION of Appellant Watson Laboratories Inc. to extend the time to 05/30/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/15/2017 by email. [415811] [Michael Nutter] [Entered: 03/15/2017 04:10 PM] (6)
Mar 15, 2017 13 **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [12] filed by Appellant Watson Laboratories Inc. Brief due 05/30/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [415847] [JCA] [Entered: 03/15/2017 04:36 PM] (0)
Feb 10, 2017 3 Entry of appearance for Adam K. Mortara as principal counsel for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GmbH and Bayer Pharma AG Bayer AG. Service: 02/10/2017 by email. [406600] [Adam Mortara] [Entered: 02/10/2017 02:56 PM] (2)
Feb 10, 2017 4 Entry of appearance for J. Scott McBride as of counsel for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GmbH and Bayer Pharma AG Bayer AG. Service: 02/10/2017 by email. [406605] [John McBride] [Entered: 02/10/2017 03:02 PM] (2)
Feb 10, 2017 5 Entry of appearance for Asha L.I. Spencer as of counsel for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GmbH and Bayer Pharma AG Bayer AG. Service: 02/10/2017 by email. [406607] [Asha Spencer] [Entered: 02/10/2017 03:05 PM] (2)
Feb 10, 2017 6 Docketing Statement for the Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GmbH and Bayer Pharma AG. Service: 02/10/2017 by email. [406614] [Adam Mortara] [Entered: 02/10/2017 03:18 PM] (4)
Feb 10, 2017 7 Certificate of Interest for the Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GmbH and Bayer Pharma AG. Service: 02/10/2017 by email. [406616] [Adam Mortara] [Entered: 02/10/2017 03:19 PM] (2)
Feb 10, 2017 8 Entry of appearance for Michael K. Nutter as of counsel for Appellant Watson Laboratories Inc.. Service: 02/10/2017 by email. [406675] [Michael Nutter] [Entered: 02/10/2017 05:46 PM] (2)
Feb 10, 2017 9 Docketing Statement for the Appellant Watson Laboratories Inc.. Service: 02/10/2017 by email. [406676] [Michael Nutter] [Entered: 02/10/2017 05:50 PM] (4)
Feb 10, 2017 10 Certificate of Interest for the Appellant Watson Laboratories Inc.. Service: 02/10/2017 by email. [406677] [Michael Nutter] [Entered: 02/10/2017 05:58 PM] (2)
Feb 10, 2017 11 Entry of appearance for George C. Lombardi as principal counsel for Appellant Watson Laboratories Inc.. Service: 02/10/2017 by email. [406681] [George Lombardi] [Entered: 02/10/2017 06:11 PM] (2)
Feb 6, 2017 2 Transcript Purchase Order Form for the Appellant Watson Laboratories Inc. indicating that a transcript is already on file. Service: 02/07/2017 by clerk. [405119] [MJL] [Entered: 02/07/2017 09:55 AM] (2)
Jan 27, 2017 1 Appeal docketed. Received: 01/26/2017. [402736]Entry of Appearance due 02/10/2017. Certificate of Interest due 02/10/2017. Docketing Statement due 02/10/2017. Appellant's brief due 03/28/2017. [MJL] [Entered: 01/27/2017 03:35 PM] (27)
Menu